|
Volumn 19, Issue 5, 2002, Pages 529-533
|
Contrast nephropathy in cardiac procedures: no advantages with prophylactic use of N-acetylcysteine (NAC);Nefropatia da contrasto in cardiologia interventistica: assenza di vantaggi con impiego profilattico di N-Acetilcisteina.
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLCYSTEINE;
CONTRAST MEDIUM;
CREATININE;
FERRIC ION;
HYPOTONIC SOLUTION;
IODIXANOL;
IODOBENZOIC ACID DERIVATIVE;
IRON;
NYCOMED;
OXIDE;
SCAVENGER;
SODIUM CHLORIDE;
ACUTE KIDNEY FAILURE;
ANGIOCARDIOGRAPHY;
ARTICLE;
BLOOD;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG ADMINISTRATION;
FLUID THERAPY;
HUMAN;
KIDNEY FUNCTION TEST;
PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY;
PREMEDICATION;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
TREATMENT FAILURE;
ACETYLCYSTEINE;
ANGIOPLASTY, BALLOON;
CONTRAST MEDIA;
CORONARY ANGIOGRAPHY;
CREATININE;
DRUG ADMINISTRATION SCHEDULE;
FERRIC COMPOUNDS;
FLUID THERAPY;
FREE RADICAL SCAVENGERS;
HUMANS;
HYPOTONIC SOLUTIONS;
IRON;
KIDNEY FAILURE, ACUTE;
KIDNEY FUNCTION TESTS;
OXIDES;
PREMEDICATION;
PROSPECTIVE STUDIES;
RISK FACTORS;
SODIUM CHLORIDE;
TREATMENT FAILURE;
TRIIODOBENZOIC ACIDS;
|
EID: 0036718178
PISSN: 03935590
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (47)
|
References (0)
|